Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

       
Total article views   HTML views PDF downloads Totals
11,096 Dovepress* 9,885+ 2,083 11,968
PubMed Central* 1,211 419 1,630
Totals 11,096 2,502 13,598
*Since 6 December 2012
+Since July 2016

View citations on PubMed Central and Google Scholar